Cameron Durrant News Today

The seaside town is expected to welcome 40,000 people as Elvis Presley tributes hit the stage.

Market temperatures are slowly rising with the summer heat. With some stocks posting double-digit gains, overvaluation concerns are becoming rife. Nevertheless, the focus is increasingly on... -Today at 03:28 am- MarketScreener

Preliminary results from the PREACH-M trial show improvement in hematologic parameters in patients with RAS-mutant chronic myelomonocytic leukemia (CMML).

Humanigen, Inc.today extended previously reported results by presenting additional, statistically significant hematologic improvements and reductions in inflammatory markers from lenzilumab, its investigational drug, in a Phase 2/3 trial of treatment-naïve participants with chronic myelomonocytic leukemia and RAS-pathway mutations.

Local news highlights in 2022

New York, NY (PRWEB) November 09, 2022 -- The Vanguard Network today announced its annual Life Sciences leadership Forum on January 23 in Cambridge, MA. The

New York (PRWEB) November 05, 2022 -- General Counsels from all industries across the US will gather in New York City for

Short Hills, New Jersey--(Newsfile Corp. - October 31, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating certain inflammatory

SHORT HILLS, N.J.--(BUSINESS WIRE)--Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on developing lenzilumab (LENZ®), a first-in class antibody that neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF), today reported financial results for the second...

Press release content from Business Wire. The AP news staff was not involved in its creation.